Headed by the institute director, Fraunhofer ITEM is organized in seven divisions, which have pooled their expertise in three business areas: Drug Development, Chemical Safety and Assessment, and Translational Biomedical Engineering. The Division of Cardiovascular Research of Prof. Thomas Thum, who has been managing Fraunhofer ITEM together with Prof. Norbert Krug since January 2021, is in the process of being established. Special expertise that is relevant for all business areas, namely in bioinformatics, comes from the corresponding project group. The Fraunhofer ITEM headquarters are in Hannover (Germany). The institute’s Division of Pharmaceutical Biotechnology has its facilities in Braunschweig on the “Science Campus Braunschweig-Süd”, and the Division of Personalized Tumor Therapy is based in Regensburg's BioPark.